Sindbis virus as a tool for quality control of viral inactivation of heated and chemically treated plasma-derived products
- 1 June 2006
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 134 (1-2) , 171-175
- https://doi.org/10.1016/j.jviromet.2006.01.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 °C terminal dry heat treatment in patients with haemophilia AHaemophilia, 2000
- Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrateHaemophilia, 1999
- Determination of Adequate Moisture Content for Efficient Dry-Heat Viral Inactivation in Lyophilized Factor VIII by Loss on Drying and by Near Infrared SpectroscopyBiologicals, 1998
- Prospective study of the evaluation of hepatitis C virus infectivity in a high‐purity, solvent/detergent‐treated factor VIII concentrate: parallel evaluation of other markers for lipid‐enveloped and non‐lipid‐ enveloped viruses.Transfusion, 1993
- Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices CommitteeTransfusion, 1993
- Acute hepatitis A in patients with haemophilia AThe Lancet, 1993
- A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaNew England Journal of Medicine, 1989
- VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 1988
- Risk of transmission of human immunodeficiency virus (HIV) by heat- treated factor VIII concentrates in patients with severe hemophilia ATransfusion, 1987
- TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATEThe Lancet, 1985